Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand (Q35749162)

10 August 2017

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand (English)

1 reference

toxic epidermal necrolysis

10 August 2017

Stevens–Johnson syndrome

1 reference

based on heuristic

inferred from title

1 reference

Riichiro Abe

1

1 reference

10 August 2017

Tadamichi Shimizu

2

1 reference

10 August 2017

Akihiko Shibaki

3

1 reference

10 August 2017

Hideki Nakamura

4

1 reference

10 August 2017

Hirokazu Watanabe

5

1 reference

10 August 2017

Hiroshi Shimizu

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

The American Journal of Pathology

10 August 2017

1 reference

10 August 2017

162

1 reference

10 August 2017

1515-1520

1 reference

10 August 2017

5

1 reference

Death receptors in cutaneous biology and disease

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Apoptosis by death factor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Burn center care for patients with toxic epidermal necrolysis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Severe adverse cutaneous reactions to drugs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Metalloproteinase-mediated release of human Fas ligand

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Toxic epidermal necrolysis treated with cyclosporin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851208

Toxic epidermal necrolysis

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Fas ligand in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964284-8

10.1016/S0002-9440(10)64284-8

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference